FTUS
CEROW

Flow Traders U.S.’s CERo Therapeutics Warrants CEROW Stock Holding History

Flow Traders U.S.’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,967
Closed -$1K – 1129
2024
Q1 		$1K Sell
17,967
-9,753
-35% -$593 ﹤0.01% 733
2023
Q4 		$1K Buy
27,720
+4,301
+18% +$134 ﹤0.01% 754
2023
Q3 		$2K Sell
23,419
-3,929
-14% -$281 ﹤0.01% 787
2023
Q2 		$2K Sell
27,348
-2,598
-9% -$113 ﹤0.01% 775
2023
Q1 		$1K Buy
29,946
+3,623
+14% +$163 ﹤0.01% 840
2022
Q4 		$1K Buy
26,323
+5,754
+28% +$303 ﹤0.01% 754
2022
Q3 		$3K Buy
20,569
+8,373
+69% +$705 ﹤0.01% 868
2022
Q2 		$1K Buy
+12,196
New +$1.97K ﹤0.01% 791

Other funds holding CEROW

HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

Flow Traders U.S.'s CEROW Position: Q2 2024 in Review

Flow Traders U.S. sold out of CERo Therapeutics Warrants (CEROW) in Q2 2024, closing a stake of 17,967 shares — an estimated $1K sold.

Flow Traders U.S. first reported a position in CEROW in Q2 2022 and held it in 8 quarters. The position peaked at $3K in Q3 2022. 34 funds tracked by Wall St. Rank hold CEROW as of Q2 2024.

  • Flow Traders U.S. reported no remaining CERo Therapeutics Warrants position as of Q2 2024 after selling out during the quarter.
  • Flow Traders U.S. sold 17,967 CERo Therapeutics Warrants shares in Q2 2024, an estimated $1K.
  • Flow Traders U.S. first reported a position in CERo Therapeutics Warrants in Q2 2022 and held it in 8 quarters.
  • Flow Traders U.S.'s CERo Therapeutics Warrants position peaked at $3K in Q3 2022.
  • 34 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q2 2024.

Based on Flow Traders U.S.'s 13F filing for Q2 2024, filed 14 Aug 2024.